The goal of this clinical trial is to evaluate the efficacy of Whole-body vibration in improving postural control, risk of falling, and quality of life in patients with chemotherapy-induced peripheral neuropathy. The main questions it aims to answer are:
Does Whole-body vibration have a significant effect on postural control, risk of falling, and quality of life in patients with chemotherapy-induced peripheral neuropathy?
Researchers will compare whole body vibration in addition to traditional exercise to traditional exercise alone to see if Whole-body vibration have a significant effect on postural control, risk of falling, and quality of life in patients with chemotherapy-induced peripheral neuropathy.
Participants will:
* age between 30-60 years old.
* be on chemotherapy for at least one cycle as a treatment of malignant tumors with peripheral neuropathy.
* have mild to moderate neuropathy according to mTNS.
* be assigned randomly into two equal groups (control group (A) and study group (B)).
* Take three sessions per week for eight weeks.
* The control group (A) will be treated by selected physical therapy treatment (Strength resistive training, Stretching \& flexibility, Balance training)
* The study group (B) will be treated with selected physical therapy treatment in addition to whole-body vibration therapy.